These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New antiarrhythmic drugs. Flaker GC; Munuswamy K Am Fam Physician; 1982 Nov; 26(5):226-32. PubMed ID: 7148632 [No Abstract] [Full Text] [Related]
8. Letter: Effects of reperfusion on antiarrhythmic drug activity. Ecanow B; Gold BH N Engl J Med; 1976 Aug; 295(8):447-8. PubMed ID: 934247 [No Abstract] [Full Text] [Related]
9. Assessment of antiarrhythmic drugs in experimental pharmacology. Caillard CG; Louis JC Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):223-52. PubMed ID: 6765586 [No Abstract] [Full Text] [Related]
10. [Mechanisms of cellular action of anti-arrhythmia agents]. Sebag C; Motté G Coeur Med Interne; 1978; 17(4):508-19. PubMed ID: 737994 [No Abstract] [Full Text] [Related]
11. [The auricular tissue specialized for conduction: its importance in physiology and antiarrhythmic pharmacotherapy]. Pastelin G; Cuevas B; Alvarado JL; Méndez R Gac Med Mex; 1984; 120(11-12):371-85. PubMed ID: 6152584 [No Abstract] [Full Text] [Related]
12. [The influence of antiarrhythmic drugs on parameters of signal-averaged electrocardiography]. Banasiak W; Bobak J; Telichowski A Przegl Lek; 1997; 54(7-8):510-4. PubMed ID: 9480459 [No Abstract] [Full Text] [Related]
13. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part I. Singh BN; Cho YW; Kuemmerle HP Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):139-51. PubMed ID: 7263102 [No Abstract] [Full Text] [Related]
14. [On the anti-arrhythmic activity of serpentine and its effect on the heart conduction system]. Gendenshteĭn EI; Mikhaĭlenko LA Farmakol Toksikol; 1965; 28(1):42-6. PubMed ID: 5845040 [No Abstract] [Full Text] [Related]
15. Atrial flutter with 1:1 atrioventricular conduction related to class I antiarrhythmic drugs for atrial tachyarrhythmias: from mechanism to predicting factors. Aouate P; Frank R; Fontaine G Int J Cardiol; 2001 Aug; 80(1):15-7. PubMed ID: 11532542 [No Abstract] [Full Text] [Related]
16. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents. Ellrodt G; Singh BN Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519 [No Abstract] [Full Text] [Related]
17. [Pharmacology of anti-arrhythmic agents (author's transl)]. Hergueta G Folia Clin Int (Barc); 1975 Dec; 25(12):661-73. PubMed ID: 1220986 [No Abstract] [Full Text] [Related]
18. [Comparative studies on heart-lung-preparation of dog. Effect of various antiarrhythmic active substances on the contractility, rate of conductivity, refractory phase and excitability of heart]. Igarashi T; Shyoji T Arzneimittelforschung; 1968 Nov; 18(11):1368-72. PubMed ID: 5755899 [No Abstract] [Full Text] [Related]
19. [The effect of naloxone on rhythm disorders and on the conduction system of the heart]. Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581 [TBL] [Abstract][Full Text] [Related]
20. [Cellular mechanism of the antiarrhythmic action of propranolol]. Kwiatkowska B; Czarnecka M; Lewartowski B Acta Physiol Pol; 1970; 21(4):441-54. PubMed ID: 5452921 [No Abstract] [Full Text] [Related] [Next] [New Search]